
Kerry Jo Lee MD
Intestinal Rehabilitation and Small Bowel Transplantation, Pediatric Hepatology and Liver Transplantation, Pediatric Inflammatory Bowel Disease Gastroenterology, Pediatric Nutrition
Physician
Join to View Full Profile
10903 New Hampshire AveSilver Spring, MD 20993
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kerry Jo Lee is a highly reputable Pediatric Gastroenterologist based in Silver Spring, MD, with additional expertise in rare disease, hepatology, and nutrition. Her extensive education includes a Residency in Pediatrics at Children's Hospital Los Angeles, graduating from New York University School of Medicine in 2007, and a Fellowship in Pediatric Gastroenterology at New York Presbyterian Hospital (Cornell Campus) from 2010 to 2013. Dr. Lee currently serves as the Associate Director for Rare Diseases at FDA, CDER where she provides strategic leadership and oversees operations for the Accelerating Rare disease Cures (ARC) Program.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Gastroenterology, 2010 - 2013
- Children's Hospital Los AngelesResidency, Pediatrics, 2007 - 2010
- New York University School of MedicineClass of 2007
Certifications & Licensure
- NY State Medical License 2010 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Publications & Presentations
PubMed
- Pivotal trial characteristics and types of endpoints used to support Food and Drug Administration rare disease drug approvals between 2013 and 2022.Kyungwan Hong, Bridget Nugent, Abbas Bandukwala, Robert Schuck, York Tomita
Clinical Trials. 2025-01-25 - 1 citationsGlobal Landscape of Benefit-Risk Considerations for Medicinal Products: Current State and Future Directions.Max Waschbusch, Lisa Rodriguez, Andreas Brueckner, Kerry Jo Lee, Xuefeng Li
Pharmaceutical Medicine. 2022-08-01 - 1 citationsThe Integrated Review: FDA Modernizes the Review of New Drug Marketing ApplicationsRhonda M. Hearns-Stewart, John Farley, Kerry Jo Lee, Sarah Connelly, Naomi Lowy
Therapeutic Innovation & Regulatory Science. 2021-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: